- The first phase of this project involved ClinVar submissions from 41 clinical laboratories, and found that 84.6% of classifications were concordant and only 2.7% (650 variants) of variants were medically significant differences (MSDs) with potential to impact medical management. Of the discrepant results that have been reviewed, 62.3% have now been resolved through data sharing
- The second, ongoing phase of this project includes all labs submitting to ClinVar (108 submitters) and preliminary data projects a 54.3% resolution rate.
- 24.3% of variants with medically significant differences between labs have been resolved within a 1 year timeframe, demonstrating conflicts will resolve through routine reassessment by laboratories, however, highlighting the outlier classification for laboratories helps to accelerate and improve conflict resolution rates